Praxis Precision Medicines Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $0-100.0% YoYTTM through 30 Jun 2026
Net Income -$303.3MTTM through 30 Jun 2026
Free Cash Flow -$305.4MTTM through 30 Jun 2026
Margins
| Current |
|---|
Returns
-23.2%ROE
-22.4%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio16.35x
Net Debt-$1.4Bnet cash position
Cash & Equivalents$474.8M
Quality Metrics
Altman Z-Score101.19
Piotroski F-Score0 / 9
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $0
Diluted EPS-$12.96TTMFY2025: $-13.48
Dividend
No dividend
Capital Allocation
R&D Spend$290.7M
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.